Characterizing P-glycoprotein and Breast Cancer Resistance Protein interactions of asciminib among other tyrosine kinase inhibitors used in chronic myeloid leukemia. Here, ABCG2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.